Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM) [Yahoo! Finance]
Sunshine Biopharma approves $5M strategic bitcoin investment [Seeking Alpha]
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections [Yahoo! Finance]
Sunshine Biopharma (NASDAQ:SBFM) had its "buy" rating reaffirmed by analysts at Aegis. They now have a $7.00 price target on the stock.
Sunshine Biopharma (NASDAQ:SBFM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.